Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events

American Journal of Clinical Pathology

Volumn 126, Issue 3, 2006, Pages 411-415

  Yang, David T ^a   Flanders, Michele M ^b   Kim, Hyunhee ^c   Rodgers, George M ^a,b,c  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Arterial thrombosis; Factor XI; Stroke

Indexed keywords

BLOOD CLOTTING FACTOR 11; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CEREBROVASCULAR DISEASE; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTHROMBIN TIME; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STROKE; THROMBOCYTE ACTIVATION; TRANSIENT ISCHEMIC ATTACK; VEIN THROMBOSIS;

EID: 33748373993     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/QC259F09UNMKVP0R     Document Type: Article

References (20)

1. Gailani D, Broze GJ Jr. Factor XI activation in a revised model of blood coagulation. Science. 1991;253:909-912.
2. Walsh PN. Platelets and factor XI bypass the contact system of blood coagulation. Thromb Haemost. 1999;82:234-242.
3. Baglia FA, Walsh PN. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or XIa. J Biol Chem. 2000;275:20514-20519.
4. Von dem Borne PA, Meijers JCM, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood. 1995;86:3035-3042.
5. Von dem Borne PA, Bajzar L, Meijers JCM, et al. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. J Clin Invest. 1997;99:2323-2327.
6. Wang W, Boffa MB, Bajzar L, et al. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activatable fibrinolysis inhibitor. J Biol Chem. 1998;273:27176-27181.
7. Meijers JCM, Tekelenburg WLH, Bouma BN, et al. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med. 2000;342:696-701.
8. Lavigne G, Mercier E, Quere I, et al. Thrombophilic families with inheritably associated high levels of coagulation factors VIII, IX and XI. J Thromb Haemost. 2003;1:2134-2139.
9. Eichinger S, Schonauer V, Weltermann A, et al. Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism. Blood. 2004;103:3773-3776.
10. Merlo C, Wuillemin WA, Redondo M, et al. Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease. Atherosclerosis. 2002;161:261-267.
11. Berliner JI, Rybicki AC, Kaplan RC, et al. Elevated levels of factor XI are associated with cardiovascular disease in women. Thromb Res. 2002;107:55-60.
12. Santamaria A, Oliver A, Borrell M, et al. Risk of ischemic stroke associated with functional thrombin-activatable fibrinolysis inhibitor plasma levels. Stroke. 2003;34:2387-2391.
13. Leebeek FWG, Van Goor MPJ, Guimaraes AHC, et al. High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke. J Thromb Haemost. 2005;3:2211-2218.
14. Montaner J, Ribo M, Monasterio J, et al. Thrombin-activatable fibrinolysis inhibitor levels in the acute phase of ischemic stroke. Stroke. 2003;34:1038-1040.
15. Flanders MM, Crist RA, Roberts WL, et al. Pediatric reference intervals for seven common coagulation assays. Clin Chem. 2005;51:1738-1742.
16. American Heart Association. Heart Disease and Stroke Statistics: 2003 Update. Dallas, TX: American Heart Association; 2002.
17. Centers for Disease Control and Prevention. Public health and aging: hospitalizations for stroke among adults aged ≥65 years: United States, 2000 [reprinted from MMWR Morb Mortal Wkly Rep. 2003;52:586-589]. JAMA. 2003;290:1023-1024.
18. Touze E, Varenne O, Chatellier G, et al. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke. 2005;36:2748-2755.
19. Warlow C, Sudlow C, Dennis M, et al. Stroke. Lancet. 2003;362:1211-1224.
20. Sudlow CLM, Warlow CP, for the International Stroke Incidence Collaboration. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke. 1997;28:491-499.